Tweet
Babble Magazine (blog)
<img alt="" height="1" width="1" />
Tail-end of swine flu boom lifts Glaxo Q1 profits
Reuters
LONDON, April 28 (Reuters) - Bumper sales of swine flu vaccine boosted GlaxoSmithKline's (GSK.L) first-quarter earnings per share 17 percent, more than expected, but the rest of 2010 may be tougher as H1N1 business wanes. While Glaxo is better placed ...
Higher Sales Boost Glaxo's NetWall Street Journal
Glaxo Earnings Beat Goals on Flu Shots; Shares GainBusinessWeek
Tail-end of swine flu helps Glaxo beat forecastsReuters UK
ShareCast -PR Urgent -Newsweek
all 74 news articles »
More...